Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009
- PMID: 20010511
Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009
Abstract
The Food and Drug Administration (FDA) licensed the first 2009 influenza A (H1N1) monovalent vaccines ("H1N1 vaccines") on September 15, 2009. The H1N1 vaccines are available as a live, attenuated monovalent vaccine (LAMV) for intranasal administration and as monovalent, inactivated, split-virus or subunit vaccines for injection (MIV). The licensure and manufacturing processes for the monovalent H1N1 vaccines were the same as those used for seasonal trivalent inactivated (TIV) or trivalent live, attenuated influenza vaccine (LAIV); none of these vaccines contains an adjuvant. Vaccine safety monitoring is an important component of all vaccination programs. To assess the safety profile of H1N1 vaccines in the United States, CDC reviewed vaccine safety results for the H1N1 vaccines from 3,783 reports received through the U.S. Vaccine Adverse Event Reporting System (VAERS) and electronic data from 438,376 persons vaccinated in managed-care organizations in the Vaccine Safety Datalink (VSD), a large, population-based database with administrative and diagnostic data, in the first 2 months of reporting (as of November 24). VAERS data indicated 82 adverse event reports per 1 million H1N1 vaccine doses distributed, compared with 47 reports per 1 million seasonal influenza vaccine doses distributed. However, no substantial differences between H1N1 and seasonal influenza vaccines were noted in the proportion or types of serious adverse events reported. No increase in any adverse events under surveillance has been seen in VSD data. Many agencies are using multiple systems to monitor H1N1 vaccine safety. Health-care providers and the public are encouraged to report adverse health events that occur after vaccination.
Similar articles
-
Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.Vaccine. 2010 Oct 21;28(45):7248-55. doi: 10.1016/j.vaccine.2010.09.021. Epub 2010 Sep 16. Vaccine. 2010. PMID: 20850534
-
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. MMWR Surveill Summ. 2003. PMID: 12825543
-
Update on influenza A (H1N1) 2009 monovalent vaccines.MMWR Morb Mortal Wkly Rep. 2009 Oct 9;58(39):1100-1. MMWR Morb Mortal Wkly Rep. 2009. PMID: 19816398
-
Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.Pediatrics. 2011 May;127 Suppl 1:S78-86. doi: 10.1542/peds.2010-1722L. Epub 2011 Apr 18. Pediatrics. 2011. PMID: 21502251 Review.
-
Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy.Expert Rev Vaccines. 2012 Aug;11(8):911-21. doi: 10.1586/erv.12.72. Expert Rev Vaccines. 2012. PMID: 23002972 Review.
Cited by
-
The first influenza pandemic of the new millennium.Influenza Other Respir Viruses. 2011 May;5(3):157-66. doi: 10.1111/j.1750-2659.2011.00231.x. Epub 2011 Feb 28. Influenza Other Respir Viruses. 2011. PMID: 21477134 Free PMC article. Review.
-
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).Vaccine. 2015 Aug 26;33(36):4398-405. doi: 10.1016/j.vaccine.2015.07.035. Epub 2015 Jul 22. Vaccine. 2015. PMID: 26209838 Free PMC article. Review.
-
Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting System.Vaccine. 2016 Aug 17;34(37):4406-14. doi: 10.1016/j.vaccine.2016.07.019. Epub 2016 Jul 19. Vaccine. 2016. PMID: 27449076 Free PMC article.
-
Hospital discharge data for Guillain-Barré syndrome and influenza A (H1N1) vaccine adverse events.Emerg Infect Dis. 2010 Sep;16(9):1500-1. doi: 10.3201/eid1609.091837. Emerg Infect Dis. 2010. PMID: 20735949 Free PMC article. No abstract available.
-
Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan.J Chin Med Assoc. 2010 Feb;73(2):62-6. doi: 10.1016/S1726-4901(10)70003-4. J Chin Med Assoc. 2010. PMID: 20171584 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical